Patients undergoing treatment for ovarian cancer respond well initially. Unfortunately, they usually relapse and their cancer develops a strong resistance to cisplatin (one of the most effective treatments.) Scientists at the National Institutes of Health are studying why and how this happens thanks to new technology from PerkinElmer.
For the first time, researchers can see the impact of chemotherapy in each cell. With innovations like this there is hope for more effective treatments.